On May 25, the U.S. House of Representatives passed the Halt All Lethal Trafficking of Fentanyl (HALT) Act (H.R. 467). The bill expands mandatory minimums for fentanyl analogue cases and permanently schedules all fentanyl-related substances as Schedule I, without first testing them for benefits or harm. Unlike other permanent scheduling bills considered by Congress this session, the HALT Fentanyl Act also includes no “offramp” provisions that would permit analogues to be descheduled if they are later found to be harmless or inert. To learn more about HR 467, host Doug McVay speaks with Liz Komar, Sentencing Reform Counsel at the Sentencing Project.
- KBOO